Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. DaVita's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.04.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, DaVita couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.
The historical rank and industry rank for DaVita's Cash-to-Debt or its related term are showing as below:
DVA'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.05 Max: 0.21
Current: 0.04
During the past 13 years, DaVita's highest Cash to Debt Ratio was 0.21. The lowest was 0.03. And the median was 0.05.
DaVita Cash-to-Debt Historical Data
The historical data trend for DaVita's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
|
DaVita Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Cash-to-Debt |
|
|
|
|
|
|
0.10 |
0.03 |
0.04 |
0.03 |
0.04 |
|
DaVita Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Cash-to-Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.03 |
0.03 |
0.03 |
0.04 |
0.04 |
Competitive Comparison
For the Medical Care Facilities subindustry, DaVita's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita Cash-to-Debt Distribution
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where DaVita's Cash-to-Debt falls into.
DaVita Cash-to-Debt Calculation
This is the ratio of a company's
Cash, Cash Equivalents, Marketable Securities
to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
DaVita's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
DaVita's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (DaVita) Business Description
Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
| Christopher Michael Berry |
officer: Chief Accounting Officer |
C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103 |
| Kathleen Alyce Waters |
officer: Chief Legal Officer |
C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202 |
| Wendy Lee Schoppert |
director |
6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442 |
| Phyllis R Yale |
director |
|
| Javier Rodriguez |
officer: Chief Executive Officer, DKC |
601 HAWAII ST., EL SEGUNDO CA 90245 |
| Barbara J Desoer |
director |
CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013 |
| James O Hearty |
officer: Chief Compliance Officer |
2000 16TH STREET, DENVER CO 80202 |
| Charles Berg |
director, officer: Executive Chair, DMG |
48 MONROE TURNPIKE, TRUMBULL CT 06611 |
| John M Nehra |
director |
1119 ST PAUL ST, BALTIMORE MD 21202 |
| Adam H Schechter |
director |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Michael David Staffieri |
officer: Chief Operating Officer, DKC |
2000 16TH STREET, DENVER CO 80202 |
| Jason M. Hollar |
director |
3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179 |
| Paula A Price |
director |
ONE CVS DRIVE, WOONSOCKET RI 02895 |
| Pamela M Arway |
director |
601 HAWAII ST., EL SEGUNDO CA 90245 |
| Gregory J. Moore |
director |
130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601 |
DaVita (DaVita) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVA has been successfully added to your